Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $8.26B | +$18.1M | 75 | 0.12% | Increased |
|
| 2 |
Fidelity Investments
Boston,
Massachusetts
| $4.84B | +$329M | 55 | 0.21% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $3.46B | -$44.9M | 65 | 0.1% | Reduced |
|
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
| $3.33B | -$142M | 72 | 0.07% | Reduced |
|
| 5 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
| $2.86B | -$120M | 43 | 0.13% | Reduced |
|
| 6 |
Fisher Asset Management
Camas,
Washington
| $2.49B | +$251M | 11 | 0.74% | Increased |
|
| 7 |
Morgan Stanley
New York
| $2.45B | -$13.7M | 77 | 0.13% | Reduced |
|
| 8 |
Jupiter Topco
New York
| $2.38B | +$2.17B | 24 | 0.97% | New |
|
| 9 |
Dimensional Fund Advisors
Austin,
Texas
| $2.13B | +$3.56M | 39 | 0.39% | Increased |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $1.85B | -$59.2M | 79 | 0.1% | Reduced |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $1.72B | -$53.5M | 52 | 0.11% | Reduced |
|
| 12 |
Goldman Sachs
New York
| $1.65B | -$494M | 56 | 0.14% | Reduced |
|
| 13 |
RTW Investments
New York
| $1.56B | +$175M | 14 | 13.29% | Increased |
|
| 14 |
Avoro Capital Advisors
New York
| $1.55B | +$31M | 4 | 13.95% | Increased |
|
| 15 |
Invesco
Atlanta,
Georgia
| $1.34B | +$92.2M | 46 | 0.11% | Increased |
|
| 16 |
Primecap Management
Pasadena,
California
| $1.2B | -$104M | 4 | 0.71% | Reduced |
|
| 17 |
Wellington Management Group
Boston,
Massachusetts
| $1.17B | +$159M | 29 | 0.2% | Increased |
|
| 18 |
Northern Trust
Chicago,
Illinois
| $1.1B | +$14M | 66 | 0.13% | Increased |
|
| 19 |
JP Morgan Chase
New York
| $1.1B | +$165M | 68 | 0.06% | Increased |
|
| 20 |
Franklin Resources
San Mateo,
California
| $1.03B | -$11.8M | 25 | 0.22% | Reduced |
|
| 21 |
Kohlberg Kravis Roberts & Co
New York
| $988M | $0 | 1 | 17.3% | Maintained |
|
| 22 |
Citadel Advisors
Miami,
Florida
| $975M | +$95.2M | 66 | 0.11% | Increased |
|
| 23 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $973M | -$49.6M | 4 | 1.22% | Reduced |
|
| 24 |
T. Rowe Price Associates
Baltimore,
Maryland
| $955M | +$59.6M | 43 | 0.1% | Increased |
|
| 25 |
Two Sigma Investments
New York
| $945M | +$95.7M | 50 | 0.68% | Increased |
|